Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tonix Pharm Hld (TNXP)

Tonix Pharm Hld (TNXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,843
  • Shares Outstanding, K 130,277
  • Annual Sales, $ 0 K
  • Annual Income, $ -28,620 K
  • 60-Month Beta 1.53
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.58
Trade TNXP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.46
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year -5.69
  • Growth Rate Est. (year over year) +98.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6125 +4.26%
on 10/26/20
0.9384 -31.95%
on 09/29/20
-0.2094 (-24.69%)
since 09/25/20
3-Month
0.6125 +4.26%
on 10/26/20
1.5200 -57.99%
on 07/31/20
-0.8114 (-55.96%)
since 07/24/20
52-Week
0.3900 +63.74%
on 02/25/20
3.9900 -83.99%
on 10/28/19
-3.3464 (-83.97%)
since 10/25/19

Most Recent Stories

More News
Tonix Pharmaceuticals Enrolls First Participant in the PRECISION Study, an Observational Study to Facilitate Development of Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics

Study May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics

TNXP : 0.6386 (-4.20%)
Compass Pathways' Historic IPO Shines Spotlight on Alternative Mental Health Treatments

, /PRNewswire/ -- Depression, anxiety, post-traumatic stress disorder (PTSD), and other mental illnesses have been prevalent in the US for quite some time, but the coronavirus pandemic has triggered a...

CMPS : 35.70 (-7.01%)
MMEDF : 0.9471 (-6.23%)
TNXP : 0.6386 (-4.20%)
NUMI.VN : 0.500 (+17.65%)
LKYSF : 0.3700 (+12.84%)
MYCO.CN : 0.215 (-8.51%)
Tonix Pharmaceuticals to Participate in BIO Investor Forum Digital

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 0.6386 (-4.20%)
Tonix Pharmaceuticals Announces Plan to Complete the Phase 3 RELIEF Study of TNX-102 SL for Management of Fibromyalgia with Currently Enrolled Participants Based on Results of Interim Analysis

Topline Results of Full Study Expected Fourth Quarter 2020

TNXP : 0.6386 (-4.20%)
Tonix Pharmaceuticals Completes Purchase of Facility to House Advanced Development Center (ADC) for Vaccine Programs

Facility Addresses the Shortage of Vaccine Production Capacity in the U.S.

TNXP : 0.6386 (-4.20%)
Sidoti Virtual Investor Conference

Sidoti & Company, LLC has released the presentation schedule, with weblink click-throughs, for Wednesday, September 23, 2020, the first day of its two-day Fall 2020 Virtual Investor Conference. The presentation...

ATEN : 6.81 (-5.02%)
ABM : 35.90 (+0.64%)
ACA : 46.75 (-2.87%)
ACU : 27.47 (+0.99%)
ALEX : 12.85 (+1.18%)
WTERD : 0.6500 (-7.14%)
AUDC : 31.46 (-0.66%)
AVA : 35.22 (+0.71%)
AZZ : 34.72 (-1.81%)
BCPC : 103.01 (-1.71%)
BBSI : 58.94 (-4.72%)
BHE : 20.55 (-4.20%)
BKH : 58.88 (-0.93%)
BRC : 41.27 (-1.46%)
CSV : 24.04 (-2.87%)
CSWI : 84.71 (-0.36%)
CTS : 26.51 (-2.32%)
DYAI : 7.73 (-0.51%)
BOOM : 35.31 (-5.61%)
NPO : 61.05 (-2.07%)
XONE : 11.25 (-6.79%)
EZPW : 4.86 (-2.02%)
FAT : 5.40 (-3.40%)
AGM : 68.99 (-0.27%)
FSS : 31.48 (-0.57%)
FORR : 37.47 (-1.39%)
GRC : 32.61 (-4.20%)
HVT : 23.39 (-1.47%)
HAYN : 16.74 (-3.63%)
HRTG : 10.90 (-1.89%)
MLHR : 33.84 (-2.79%)
HSKA : 114.63 (-4.75%)
HNI : 35.09 (-3.60%)
HOFT : 29.36 (-2.39%)
HOTH : 1.8000 (-4.26%)
HURN : 41.91 (-1.64%)
ICFI : 69.58 (-2.21%)
IMMR : 6.78 (-3.14%)
INFU : 13.41 (unch)
IIIN : 21.33 (-1.30%)
INS : 39.08 (-4.68%)
KAI : 117.33 (-2.23%)
LZB : 35.70 (-1.73%)
LMAT : 33.23 (+1.25%)
LPTH : 2.36 (+2.16%)
LINC : 5.24 (-3.32%)
MTX : 57.63 (-1.67%)
MG : 3.89 (-1.27%)
MOD : 6.83 (-4.74%)
NP : 39.05 (-1.29%)
ODP : 21.49 (-3.59%)
CNXN : 46.62 (-2.06%)
PBI : 7.54 (-0.92%)
POWL : 24.34 (-3.18%)
PRIM : 19.73 (-1.15%)
QADA : 43.68 (-3.55%)
KWR : 191.91 (-2.70%)
RDNT : 15.86 (-0.44%)
SWM : 33.26 (-2.52%)
SREV : 1.4100 (-4.08%)
STRA : 93.86 (-2.39%)
SYX : 23.46 (-3.14%)
TTEC : 57.88 (-2.64%)
TTEK : 104.33 (-2.07%)
TWI : 2.93 (+4.64%)
TNXP : 0.6386 (-4.20%)
TRNS : 27.50 (+1.51%)
UFI : 13.21 (-0.68%)
UEIC : 40.29 (+1.72%)
UTI : 5.25 (+0.57%)
VVI : 20.98 (-6.80%)
VPG : 25.62 (-2.25%)
WGO : 48.38 (+0.08%)
YTRA : 1.0500 (-11.02%)
New Technologies Arise to Help Prevent the Spread of Diseases

, /PRNewswire/ -- Due to increasing awareness amongst consumers on hygiene and preventive healthcare, the global surface disinfectant market is anticipated to grow significantly in the coming years. The...

OPTI : 0.0280 (-5.08%)
RLFTF : 0.5790 (+7.22%)
TNXP : 0.6386 (-4.20%)
TTNP : 0.1497 (+9.11%)
NOVN : 0.5129 (+0.57%)
Tonix Pharmaceuticals to Host Live Webinar: Antibody vs. T Cell Immunity: Is a Single Vaccine Enough to Stop COVID-19?

Webinar to be Moderated by Clive Cookson of the Financial Times on September 24, 2020

MRK : 78.84 (-1.24%)
TNXP : 0.6386 (-4.20%)
Tonix Pharmaceuticals Enrolls First Patient in COV-LOGIC, an Observational Study to Assess Antibody and T Cell Responses to SARS-CoV-2, the Virus that Causes COVID-19

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the first patient was enrolled in the observational COV-LOGIC...

TNXP : 0.6386 (-4.20%)
Tonix Pharmaceuticals Initiates Enrollment in Second Potentially Pivotal Phase 3 Study, the RALLY Study, of TNX-102 SL for the Management of Fibromyalgia

Interim Analysis Results from Ongoing Phase 3 RELIEF Study Expected in September; Topline Results Expected in Fourth Quarter 2020

TNXP : 0.6386 (-4.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102,...

See More

Key Turning Points

2nd Resistance Point 0.7109
1st Resistance Point 0.6748
Last Price 0.6386
1st Support Level 0.6075
2nd Support Level 0.5763

See More

52-Week High 3.9900
Fibonacci 61.8% 2.6148
Fibonacci 50% 2.1900
Fibonacci 38.2% 1.7652
Last Price 0.6386
52-Week Low 0.3900

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar